| 网站首页 | 眼科中心 | 协和眼科 | 会议中心 | 医学资源 | 精美图片 | 眼科宝贝 | 论坛 | 淘宝网店 | 会员中心 | 帮助中心 | 换眼科点 | 申请权限 | 全站搜索 | 博客 | 
最新公告:

  没有公告

您现在的位置: 眼科医生网 >> 会议中心 >> 第16届全国会 >> 正文
专题栏目
更多内容
相关文章
更多内容
The Role of Bone Marrow-Derived Mesenchymal Stem Cells in Corneal Tissue Repair           ★★★
The Role of Bone Marrow-Derived Mesenchymal Stem Cells in Corneal Tissue Repair
作者:不详 文章来源:Sydney and Sydney Eye Hospital 点击数: 更新时间:2011-9-13
Objectives: Considering that there is a shortage of eye donor, the aim of corneal tissue engineering is to develop substitutes for the replacement of damaged tissues. Limbal stem cells have been considered as a source for continual renewal of corneal epithelium; however, it has limitation on the ocular surface disorders with limbal stem cell dysfunction. In addition, there is no reliable source for regeneration of corneal endothelium. This study is to investigate the ability of differentiation of bone marrow-derived mesenchymal stem cells (BMMSC) into corneal cells in vitro and their possible roles in corneal repair.
Methods: Bone marrow was collected from the femoral and tibial bones of WISTAR Albino rats. The MSCs were isolated and cultured with Ficoll Hypaque gradient method. The purification of MSCs was achieved by removal of nonadherent cells during subsequent changes of medium. Bone marrow derived cells were characterised for the presence of mesenchymal marker (CD29) and absence of hematopoietic marker (CD34) before performing experiments. MSC to epithelium and endothelium differentiation experiments were performed. The epithelial cells differentiated from BMMSCs were characterised by morphology and immunophenotyping using K3, ZO-1. The flow cytometry and Western blot were also used to confirm the cell differentiation. Epithelial and endothelial cell proliferation assays using various MSC mixed-cultures and MSC conditional medium were also conducted. 
Results: Primary cultures of BMMSCs were obtained successfully. Immunohistochemistry study and flow cytometry analysis indicated that BMMSCs constantly expressed CD29 (mesenchymal marker). They were negative for CD34 (hematopoietic marker). In the induction of multi-lineage differentiation experiments, corneal epithelial cells were successfully differentiated from BMMSCs. Those cells were Cytokeratin 3 (corneal epithelial marker) and ZO-1 positive and CD 31 (endothelial marker) negative. The original MSC marker of CD29 was switched to negative on those differentiated epithelial cells. The endothelial-like cells were observed from the MSC cultures induced with corneal endothelial growth factor. The cells were ZO-1 positive. However they could not be characterised due to the lack of available specific corneal endothelial markers. SMCs showed promotion effects on corneal cell proliferation. 
Conclusion: The present study demonstrates that bone marrow-derived mesenchymal stem cells have the ability to differentiate into corneal epithelial and endothelial-like cells. The study opens up the possibility of using these cells in corneal tissue engineering and regeneration in the treatment of corneal surface disorders. This project is supported by Corneal Stem Cell Research Grant of Save Sight Institute and Dr McClellan’s Corneal Research Donation Fund.
会议投稿录入:毛进    责任编辑:毛进 
  • 上一篇会议投稿:

  • 下一篇会议投稿: 没有了
  • 【字体: 】【发表评论】【加入收藏】【告诉好友】【打印此文】【关闭窗口
      网友评论:(只显示最新10条。评论内容只代表网友观点,与本站立场无关!)

    | 设为首页 | 加入收藏 | 联系站长 | 友情链接 | 版权申明 |
    眼科医生网 眼科医生网版权所有 @ 1998-2008
    部分文章和资源来源于网络,如果侵犯了您的版权,请指出! 站长:毛进
    信息产业部备案
    *京ICP备05085871